Table 1.
Clinical characteristics of the patients
| Lesion | Soleus Ashworth score | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients | BoNT | Time | Type | Site | Soleus | MG | LG | TP | PreBoNT | PostBoNT | Inh. |
| 1.M.70 | Y | 10 | Isch. | R | 3 | — | — | — | 4 | 3 | 8.6 |
| 2.M.56 | Y | 42 | Hem. | L | 3 | — | — | — | 5 | 5 | −6.1 |
| 3.M.71 | Y | 21 | Isch. | R | 3 | 1 | — | — | 5 | 4 | −11.0 |
| 4.M.51 | Y | 38 | HI+Hem. | L | 3 | — | — | — | 5 | 4 | −14.4 |
| 5.F.73 | — | 8 | Hem. | L | 3 | — | — | — | 5 | 4 | −26.7 |
| 6.M.61 | — | 15 | Hem. | L | 3 | 1 | 1 | 1 | 4 | 2 | −31.4 |
| 7.F.75 | Y | 21 | Isch. | R | 3 | 1 | — | — | 5 | 3 | −36.3 |
| 8.M.73 | Y | 20 | Isch. | R | 3 | — | 1 | — | 3 | 3 | −49.6 |
| 9.M.49 | — | 5 | Isch. | L | 3 | 1 | 1 | — | 4 | 2 | −58.9 |
| 10.F.51 | Y | 18 | Isch.+Hem. | R | 3 | — | — | 1 | 5 | 4 | −67.7 |
| 11.M.64 | — | 14 | Isch. | L | 3 | 1 | 1 | — | 4 | 3 | −71.0 |
| 12.M.63 | — | 3 | Isch. | R | 3 | 1 | 1 | — | 4 | 2 | −80.2 |
| 13.M.50 | — | 6 | Isch. | R | 3 | 1 | 1 | 1 | 4 | 2 | −96.4 |
| 14.F.54 | — | 2 | Isch. | R | 3 | 1 | 1 | — | 4 | 2 | −100 |
Patients: rank, gender (M, male; F, female), and age at the time of the investigation (years); BoNT indicates if the patients had received BoNT-A at least 3 months before the investigation (Y), or not (—); Lesion: Time = Time lapse between stroke and the first electrophysiological investigation before BoNT-A (months); Type = origin of the lesion (Isch., ischaemia; Hem., haemorrhage; HI, head injury); Site = cerebral hemisphere affected; Number of injection sites in muscles receiving BoNT-A: soleus, MG (medial gasctrocnemius), LG (lateral gasctrocnemius), and TP (tibialis posterior); soleus Ashworth score: estimation of muscle tone in soleus before (PreBoNT) and 1 month after toxin injection (PostBoNT); Inh. = change in inhibition 1 month after BoNT-A (Recurrent inhibition (RI) postBoNT-A – RI preBoNT-A/RI preBoNT-A)×100%.